Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-019503
Filing Date
2025-07-08
Accepted
2025-07-08 16:19:02
Documents
1
Period of Report
2025-07-03

Document Format Files

Seq Description Document Type Size
1 form4-07082025_080758.html 4  
1 form4-07082025_080758.xml 4 3463
  Complete submission text file 0001415889-25-019503.txt   4842
Mailing Address 2500 INNOVATION WAY GREENFIELD IN 46140
Business Address 2500 INNOVATION WAY GREENFIELD IN 46140 877-352-6261
Elanco Animal Health Inc (Issuer) CIK: 0001739104 (see all company filings)

EIN.: 825497352 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ELANCO ANIMAL HEALTH, INC. 2500 INNOVATION WAY GREENFIELD IN 46140
Business Address
Meer James M (Reporting) CIK: 0001754243 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38661 | Film No.: 251111247